Saturday, 29th of July 2017 |
The Lancet, Volume 390, No. 10093, p451–452, 29 July 2017
Correspondence
Collaborating to achieve Global Vaccine Action Plan goals
Alan R Hinman,
Walter A OrensteinEmail the author Walter A Orenstein
Published: 29 July 2017
DOI: http://dx.doi.org/10.1016/S0140-6736(17)31370-3
In their Comment, Margaret Chan and colleagues1 (Feb 25, p 777) highlight the progress being made to achieve the goals of the Global Vaccine Action Plan (GVAP)2 and the results of the mid-term review of progress issued by WHOs Strategic Advisory Group of Experts (SAGE) on immunisation.3 They also summarise the remaining challenges and call on all stakeholders to do more to achieve GVAP goals.
We believe the remaining challenges fall into six categories: inadequate support by donors and governments to strengthen ongoing immunisation services, insufficient stress on and support for surveillance to guide programme strategies and operations, too little learning from outbreak investigations, deficient communication or collaboration between the various components of the global immunisation enterprise, inequities among and within countries, and unsatisfactory national commitments to sustain immunisation programmes into the future.
Although mechanisms to facilitate coordination and cooperation between global immunisation partners currently exist, they are insufficient to address the many unmet needs of countries and partners and to provide the structure and support needed to achieve the GVAP goals. A new approach is urgently needed. We propose convening a new GVAP coalition that is complementary to existing mechanisms of partner coordination and whose aims are to achieve the GVAP goals, including its disease reduction targets, by taking a global perspective that encompasses all countries. The coalitions primary purpose would be to work at global and national levels to facilitate collaborative action, contributing to and building from what now exists and involving a broader range of partner organisations. The coalition would also serve as a collaborative mechanism for advocacy, resource mobilisation, and accountability.
We declare no competing interests.
References
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
40954334 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |